Scorpio Gold (SGN) Stock Price, News & Analysis

Company Overview

Scorpio Gold Corporation, together with its subsidiaries, engages in the exploitation, exploration, and development of mineral resource properties in the United States. It primarily explores for gold and silver deposits. The company holds 100% interests in the Mineral Ridge gold project covering an area of 5,617 hectares located in Esmeralda County, Nevada; and Goldwedge property that covers an area of 726 hectares located in Manhattan, Nevada. The company is based in Vancouver, Canada.

Key Stats

• Today's Range: C$0.13 to C$0.13
• 50-Day Range: C$0.12 to C$0.19
• 52-Week Range: C$0.10 to C$0.33
• Volume: 20,000 shs
• Average Volume: 127,630 shs
• Market Capitalization: C$13.68 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SGN Stock Analysis - Frequently Asked Questions

How have SGN shares performed this year?

Scorpio Gold's stock was trading at C$0.19 on January 1st, 2024. Since then, SGN stock has decreased by 34.2% and is now trading at C$0.13.
View the best growth stocks for 2024 here.

How were Scorpio Gold's earnings last quarter?

Scorpio Gold Co. (CVE:SGN) released its earnings results on Tuesday, August, 27th. The company reported $0.03 earnings per share for the quarter.

How do I buy shares of Scorpio Gold?

Shares of SGN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Scorpio Gold own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Scorpio Gold investors own include Antibe Therapeutics (ATE), Journey Energy (JOY), Yorbeau Resources (YRB), Medical Facilities (DR), Alimentation Couche-Tard (ATD.B), Arrowhead Pharmaceuticals (ARWR) and Argonaut Gold (AR).

Company Calendar

• Last Earnings: 8/27/2024
• Today: 11/21/2024
• Next Earnings (Estimated): 12/04/2024

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Basic Materials
• Industry: Gold
• Sub-Industry: Business Services
• Current Symbol: CVE:SGN
• CUSIP: N/A
• CIK: N/A
• Web: www.scorpiogold.com
• Phone: +1-604-6789639
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.08)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-2,690,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -49.77%
• Return on Assets: -10.94%

Debt

• Debt-to-Equity Ratio: 53.01
• Current Ratio: 0.21
• Quick Ratio: 0.39

Sales & Book Value

• Annual Sales: C$839,000.00
• Price / Sales: 16.30
• Cash Flow: C$0.02 per share
• Price / Cash Flow: 7.50
• Book Value: C$0.08 per share
• Price / Book: 1.56

Miscellaneous

• Outstanding Shares: 109,410,000
• Free Float: N/A
• Market Cap: C$13.68 million
• Optionable: Not Optionable
• Beta: 1.22